Oral ELZ (25–100 mg/kg/day for 7days), or plasma and peritoncal resident cells from lysozyme treated mice to mice bearing mammary carcinoma of CBA mouse mammary carcinoma. The gene discussed is LYZ; the disease is breast carcinoma.